Skip to main content
. 2022 Dec 14;118(5):861–871. doi: 10.14309/ajg.0000000000002129

Table 2.

Effectiveness of tofacitinib for achieving clinical and endoscopic remission in patients with ulcerative colitis

graphic file with name acg-118-861-g003.jpg